<?xml version="1.0" encoding="UTF-8" standalone="no"?>

<MINiML
   xmlns="http://www.ncbi.nlm.nih.gov/geo/info/MINiML"
   xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
   xsi:schemaLocation="http://www.ncbi.nlm.nih.gov/geo/info/MINiML http://www.ncbi.nlm.nih.gov/geo/info/MINiML.xsd"
   version="0.5.0" >

  <Contributor iid="contrib1">
    <Person><First>Izabela</First><Last>Sitkiewicz</Last></Person>
    <Email>iza.sitkiewicz@gmail.com</Email>
    <Department>Epidemiology and Clinical Microbiology</Department>
    <Organization>National Medicines Institute</Organization>
    <Address>
      <Line>Chełmska 30/34</Line>
      <City>Warsaw</City>
      <Postal-Code>00-725</Postal-Code>
      <Country>Poland</Country>
    </Address>
  </Contributor>

  <Contributor iid="contrib2">
    <Person><First>Laurent</First><Last>Mereghetti</Last></Person>
  </Contributor>

  <Contributor iid="contrib3">
    <Person><First>Nicole</First><Middle>M</Middle><Last>Green</Last></Person>
  </Contributor>

  <Contributor iid="contrib4">
    <Person><First>James</First><Middle>M</Middle><Last>Musser</Last></Person>
  </Contributor>

  <Database iid="GEO">
    <Name>Gene Expression Omnibus (GEO)</Name>
    <Public-ID>GEO</Public-ID>
    <Organization>NCBI NLM NIH</Organization>
    <Web-Link>http://www.ncbi.nlm.nih.gov/geo</Web-Link>
    <Email>geo@ncbi.nlm.nih.gov</Email>
  </Database>

  <Platform iid="GPL6923">
    <Status database="GEO">
      <Submission-Date>2008-06-03</Submission-Date>
      <Release-Date>2008-09-01</Release-Date>
      <Last-Update-Date>2008-09-01</Last-Update-Date>
    </Status>
    <Title>TMHRI Streptococcus agalactiae 2K array version1</Title>
    <Accession database="GEO">GPL6923</Accession>
    <Technology>in situ oligonucleotide</Technology>
    <Distribution>custom-commercial</Distribution>
    <Organism taxid="1311">Streptococcus agalactiae</Organism>
    <Manufacturer>Affymetrix</Manufacturer>
    <Manufacture-Protocol>
Standard Affymetrix procedures
    </Manufacture-Protocol>
    <Catalog-Number>N/A</Catalog-Number>
    <Contributor-Ref ref="contrib2" position="1" />
    <Contributor-Ref ref="contrib1" position="2" />
    <Contributor-Ref ref="contrib3" position="3" />
    <Contributor-Ref ref="contrib4" position="4" />
    <Contact-Ref ref="contrib1" />
    <Data-Table>
      <Column position="1">
        <Name>ID</Name>
      </Column>
      <Column position="2">
        <Name>GB_ACC</Name>
        <Description>Nucleotide accesion number </Description>
        <Link-Prefix>http://www.ncbi.nlm.nih.gov/sites/entrez?db=nucleotide&amp;cmd=search&amp;term=</Link-Prefix>
      </Column>
      <Column position="3">
        <Name>PT_GI</Name>
        <Description>Protein gi numbers </Description>
        <Link-Prefix>http://www.ncbi.nlm.nih.gov/sites/entrez?db=protein&amp;cmd=search&amp;term=</Link-Prefix>
      </Column>
      <Column position="4">
        <Name>ORF</Name>
        <Description>locus tag from NC_004368  </Description>
        <Link-Prefix>http://www.ncbi.nlm.nih.gov/sites/entrez?db=gene&amp;cmd=search&amp;term=</Link-Prefix>
        <Link-Suffix>[gene name] AND Streptococcus agalactiae[organism]</Link-Suffix>
      </Column>
      <Column position="5">
        <Name>Identifier Source</Name>
        <Description>database name</Description>
      </Column>
      <Column position="6">
        <Name>Description</Name>
        <Description>putative function</Description>
      </Column>
      <Column position="7">
        <Name>Sequence Type</Name>
        <Description>control or mRNA</Description>
      </Column>
      <Column position="8">
        <Name>chromStart</Name>
        <Description>start coordinates</Description>
      </Column>
      <Column position="9">
        <Name>chromEnd</Name>
        <Description>stop coordinates</Description>
      </Column>
      <Column position="10">
        <Name>GENOME_ACC</Name>
      </Column>
      <Column position="11">
        <Name>length</Name>
        <Description>ORF length</Description>
      </Column>
      <Column position="12">
        <Name>species</Name>
      </Column>
      <Column position="13">
        <Name>orientation</Name>
        <Description>coding strain + or -</Description>
      </Column>
      <Column position="14">
        <Name>ergoId</Name>
        <Description>ID in ERGO database</Description>
      </Column>
      <Column position="15">
        <Name>SPOT_ID</Name>
        <Description>identifies controls</Description>
      </Column>
    <External-Data rows="2136">
GPL6923-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Platform>

  <Sample iid="GSM307022">
    <Status database="GEO">
      <Submission-Date>2008-07-22</Submission-Date>
      <Release-Date>2009-06-01</Release-Date>
      <Last-Update-Date>2009-03-22</Last-Update-Date>
    </Status>
    <Title>Expression of S. agalactiae genes in blood at time 0 (donor A)</Title>
    <Accession database="GEO">GSM307022</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Growth in blood</Source>
      <Organism taxid="1311">Streptococcus agalactiae</Organism>
      <Characteristics>
Strain NEM316 grown in blood
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Each blood with bacteria sample was treated with 2 volumes of RNAprotect Bacteria Reagent (Qiagen, Valencia, CA), collected by centrifugation, and stored at –80°C until processing. Red cells were lyzed by Erythocyte Lysis (EL) buffer (Qiagen). RNA was extracted using the Lysing Matrix B microtubes containing 0.1 mm silica spheres (Qbiogene, Carlsbad, CA) and 1 mL Trizol (Invitrogen) with the FastPrep FP120 cell disrupter (Qbiogene). RNA extraction was completed with the RNeasy Mini kit (Qiagen) according to the manufacturer’s instructions. 
      </Extract-Protocol>
      <Label>Biotin</Label>
      <Label-Protocol>
Standard Affymetrix
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Overnight 45°C, standard Affymetrix protocol
    </Hybridization-Protocol>
    <Scan-Protocol>
Affymetrix Genechip scanner 3000
    </Scan-Protocol>
    <Description>
Part of series of experiments performed to determine response of S. agalactiae to human blood
    </Description>
    <Data-Processing>
Raw data normalized to total signal intensity of S. agalactiae probes present on the array
    </Data-Processing>
    <Platform-Ref ref="GPL6923" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM307nnn/GSM307022/GSM307022.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>normalized hybridization value</Description>
      </Column>
      <Column position="3">
        <Name>DETECTION_BL1</Name>
        <Description>(A) absent, (P) present or (M) marginal level of transcription</Description>
      </Column>
    <External-Data rows="2136">
GSM307022-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM307024">
    <Status database="GEO">
      <Submission-Date>2008-07-22</Submission-Date>
      <Release-Date>2009-06-01</Release-Date>
      <Last-Update-Date>2009-03-22</Last-Update-Date>
    </Status>
    <Title>Expression of S. agalactiae genes in blood after 30 minutes at 37°C (donor A)</Title>
    <Accession database="GEO">GSM307024</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Growth in blood</Source>
      <Organism taxid="1311">Streptococcus agalactiae</Organism>
      <Characteristics>
Strain NEM316 grown in blood
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Each blood with bacteria sample was treated with 2 volumes of RNAprotect Bacteria Reagent (Qiagen, Valencia, CA), collected by centrifugation, and stored at –80°C until processing. Red cells were lyzed by Erythocyte Lysis (EL) buffer (Qiagen). RNA was extracted using the Lysing Matrix B microtubes containing 0.1 mm silica spheres (Qbiogene, Carlsbad, CA) and 1 mL Trizol (Invitrogen) with the FastPrep FP120 cell disrupter (Qbiogene). RNA extraction was completed with the RNeasy Mini kit (Qiagen) according to the manufacturer’s instructions. 
      </Extract-Protocol>
      <Label>Biotin</Label>
      <Label-Protocol>
Standard Affymetrix
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Overnight 45°C, standard Affymetrix protocol
    </Hybridization-Protocol>
    <Scan-Protocol>
Affymetrix Genechip scanner 3000
    </Scan-Protocol>
    <Description>
Part of series of experiments performed to determine response of S. agalactiae to human blood
    </Description>
    <Data-Processing>
Raw data normalized to total signal intensity of S. agalactiae probes present on the array
    </Data-Processing>
    <Platform-Ref ref="GPL6923" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM307nnn/GSM307024/GSM307024.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>normalized hybridization value</Description>
      </Column>
      <Column position="3">
        <Name>DETECTION_BL2</Name>
        <Description>(A) absent, (P) present or (M) marginal level of transcription</Description>
      </Column>
    <External-Data rows="2136">
GSM307024-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM307025">
    <Status database="GEO">
      <Submission-Date>2008-07-22</Submission-Date>
      <Release-Date>2009-06-01</Release-Date>
      <Last-Update-Date>2009-03-22</Last-Update-Date>
    </Status>
    <Title>Expression of S. agalactiae genes in blood after 90 minutes at 37°C (donor A)</Title>
    <Accession database="GEO">GSM307025</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Growth in blood</Source>
      <Organism taxid="1311">Streptococcus agalactiae</Organism>
      <Characteristics>
Strain NEM316 grown in blood
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Each blood with bacteria sample was treated with 2 volumes of RNAprotect Bacteria Reagent (Qiagen, Valencia, CA), collected by centrifugation, and stored at –80°C until processing. Red cells were lyzed by Erythocyte Lysis (EL) buffer (Qiagen). RNA was extracted using the Lysing Matrix B microtubes containing 0.1 mm silica spheres (Qbiogene, Carlsbad, CA) and 1 mL Trizol (Invitrogen) with the FastPrep FP120 cell disrupter (Qbiogene). RNA extraction was completed with the RNeasy Mini kit (Qiagen) according to the manufacturer’s instructions. 
      </Extract-Protocol>
      <Label>Biotin</Label>
      <Label-Protocol>
Standard Affymetrix
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Overnight 45°C, standard Affymetrix protocol
    </Hybridization-Protocol>
    <Scan-Protocol>
Affymetrix Genechip scanner 3000
    </Scan-Protocol>
    <Description>
Part of series of experiments performed to determine response of S. agalactiae to human blood
    </Description>
    <Data-Processing>
Raw data normalized to total signal intensity of S. agalactiae probes present on the array
    </Data-Processing>
    <Platform-Ref ref="GPL6923" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM307nnn/GSM307025/GSM307025.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>normalized hybridization value</Description>
      </Column>
      <Column position="3">
        <Name>DETECTION_BL3</Name>
        <Description>(A) absent, (P) present or (M) marginal level of transcription</Description>
      </Column>
    <External-Data rows="2136">
GSM307025-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM307026">
    <Status database="GEO">
      <Submission-Date>2008-07-22</Submission-Date>
      <Release-Date>2009-06-01</Release-Date>
      <Last-Update-Date>2009-03-22</Last-Update-Date>
    </Status>
    <Title>Expression of S. agalactiae genes in blood after 30 minutes at 40°C (donor A)</Title>
    <Accession database="GEO">GSM307026</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Growth in blood</Source>
      <Organism taxid="1311">Streptococcus agalactiae</Organism>
      <Characteristics>
Strain NEM316 grown in blood
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Each blood with bacteria sample was treated with 2 volumes of RNAprotect Bacteria Reagent (Qiagen, Valencia, CA), collected by centrifugation, and stored at –80°C until processing. Red cells were lyzed by Erythocyte Lysis (EL) buffer (Qiagen). RNA was extracted using the Lysing Matrix B microtubes containing 0.1 mm silica spheres (Qbiogene, Carlsbad, CA) and 1 mL Trizol (Invitrogen) with the FastPrep FP120 cell disrupter (Qbiogene). RNA extraction was completed with the RNeasy Mini kit (Qiagen) according to the manufacturer’s instructions. 
      </Extract-Protocol>
      <Label>Biotin</Label>
      <Label-Protocol>
Standard Affymetrix
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Overnight 45°C, standard Affymetrix protocol
    </Hybridization-Protocol>
    <Scan-Protocol>
Affymetrix Genechip scanner 3000
    </Scan-Protocol>
    <Description>
Part of series of experiments performed to determine response of S. agalactiae to human blood
    </Description>
    <Data-Processing>
Raw data normalized to total signal intensity of S. agalactiae probes present on the array
    </Data-Processing>
    <Platform-Ref ref="GPL6923" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM307nnn/GSM307026/GSM307026.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>normalized hybridization value</Description>
      </Column>
      <Column position="3">
        <Name>DETECTION_BL4</Name>
        <Description>(A) absent, (P) present or (M) marginal level of transcription</Description>
      </Column>
    <External-Data rows="2136">
GSM307026-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM307027">
    <Status database="GEO">
      <Submission-Date>2008-07-22</Submission-Date>
      <Release-Date>2009-06-01</Release-Date>
      <Last-Update-Date>2009-03-22</Last-Update-Date>
    </Status>
    <Title>Expression of S. agalactiae genes in blood after 90 minutes at 40°C (donor A)</Title>
    <Accession database="GEO">GSM307027</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Growth in blood</Source>
      <Organism taxid="1311">Streptococcus agalactiae</Organism>
      <Characteristics>
Strain NEM316 grown in blood
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Each blood with bacteria sample was treated with 2 volumes of RNAprotect Bacteria Reagent (Qiagen, Valencia, CA), collected by centrifugation, and stored at –80°C until processing. Red cells were lyzed by Erythocyte Lysis (EL) buffer (Qiagen). RNA was extracted using the Lysing Matrix B microtubes containing 0.1 mm silica spheres (Qbiogene, Carlsbad, CA) and 1 mL Trizol (Invitrogen) with the FastPrep FP120 cell disrupter (Qbiogene). RNA extraction was completed with the RNeasy Mini kit (Qiagen) according to the manufacturer’s instructions. 
      </Extract-Protocol>
      <Label>Biotin</Label>
      <Label-Protocol>
Standard Affymetrix
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Overnight 45°C, standard Affymetrix protocol
    </Hybridization-Protocol>
    <Scan-Protocol>
Affymetrix Genechip scanner 3000
    </Scan-Protocol>
    <Description>
Part of series of experiments performed to determine response of S. agalactiae to human blood
    </Description>
    <Data-Processing>
Raw data normalized to total signal intensity of S. agalactiae probes present on the array
    </Data-Processing>
    <Platform-Ref ref="GPL6923" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM307nnn/GSM307027/GSM307027.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>normalized hybridization value</Description>
      </Column>
      <Column position="3">
        <Name>DETECTION_BL5</Name>
        <Description>(A) absent, (P) present or (M) marginal level of transcription</Description>
      </Column>
    <External-Data rows="2136">
GSM307027-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Series iid="GSE12201">
    <Status database="GEO">
      <Submission-Date>2008-07-22</Submission-Date>
      <Release-Date>2009-06-01</Release-Date>
      <Last-Update-Date>2012-03-20</Last-Update-Date>
    </Status>
    <Title>Differential Streptococcus agalactiae gene expression in human blood according to the blood donors</Title>
    <Accession database="GEO">GSE12201</Accession>
    <Pubmed-ID>19774088</Pubmed-ID>
    <Summary>
In the present investigation, we conducted a bacterial transcriptome dynamics analysis during GBS incubation with human blood. We observed large modification in the expression of numerous genes, but GBS transcriptome was different with the blood of one donor. More genes were up-regulated and less down-regulated in respect to the other donors.
    </Summary>
    <Overall-Design>
The serotype III GBS reference strain NEM316 was cultivated in Todd Hewitt broth supplemented with 0.2% yeast extract (THY) in 5% CO2 at 37°C until OD reached 0.7. Culture was harvested by centrifugation 8 minutes at 4000 x g at 37°C, then suspended in phosphate-buffered saline (PBS).
Fresh heparinized human blood was obtained from one healthy volunteer in accordance  with a protocol approved by the Institutional Review Board of the Methodist Hospital Research Institute. The blood was maintained at 37°C no more than one hour prior to use. Bacterial suspension was then incubated with theblood at 37°C and 40°C under slight rotation to avoid sedimentation of blood and bacterial cells. Samples were removed for microarrays analysis immediately after adding bacteria, and after 30 and 90 minutes of incubation.
Thus, we obtained results for five time points: immediately after mixing the bacterium with the blood (time 0), after 30 minutes of contact with blood (time 1) at 37°C and 40°C, and after after 90 minutes of contact with blood (time 1) at 37°C and 40°C.
    </Overall-Design>
    <Type>Expression profiling by array</Type>
    <Contributor-Ref ref="contrib2" position="1" />
    <Contributor-Ref ref="contrib1" position="2" />
    <Contributor-Ref ref="contrib3" position="3" />
    <Contributor-Ref ref="contrib4" position="4" />
    <Contact-Ref ref="contrib1" />
    <Sample-Ref ref="GSM307022" />
    <Sample-Ref ref="GSM307024" />
    <Sample-Ref ref="GSM307025" />
    <Sample-Ref ref="GSM307026" />
    <Sample-Ref ref="GSM307027" />
    <Supplementary-Data type="TAR">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/series/GSE12201/GSE12201_RAW.tar
    </Supplementary-Data>
    <Relation type="BioProject" target="http://www.ncbi.nlm.nih.gov/bioproject/113427" />
  </Series>

</MINiML>
